Table 3.
Correlations between BCRP-PID score and recurrence or survival.
| n | BCRP-PID Score (Mean ± S.E.) | 95% CI | p-Value * | ||
|---|---|---|---|---|---|
| CNB (n = 28) | No Recurrence | 12 | 14.3 ± 1.2 | 11.9–16.6 | 0.30 |
| Recurrence | 16 | 15.9 ± 1.0 | 13.8–17.9 | ||
| PT (n = 37) | No recurrence | 16 | 13.7 ± 1.8 | 1.8–10.1 | 0.61 |
| Recurrence | 21 | 14.9 ± 1.5 | 1.5–11.8 | ||
| LN (n = 37) | No recurrence | 16 | 10.3 ± 1.2 | 7.8–12.8 | 0.61 |
| Recurrence | 21 | 11.1 ± 1.1 | 9.0–13.3 | ||
| PT + LN (n = 37) | No recurrence | 16 | 24.0 ± 2.0 | 19.9–28.1 | 0.45 |
| Recurrence | 21 | 26.0 ± 1.8 | 22.5–29.6 | ||
| CNB (n = 28) | Survival | 18 | 14.2 ± 0.9 | 12.3–16.0 | 0.07 |
| Death | 10 | 17.0 ± 1.2 | 14.5–19.5 | ||
| PT (n = 37) | Survival | 22 | 13.4 ± 1.5 | 10.4–16.5 | 0.32 |
| Death | 15 | 15.8 ± 1.8 | 12.1–19.4 | ||
| LN (n = 37) | Survival | 22 | 10.3 ± 1.0 | 8.2–12.4 | 0.45 |
| Death | 15 | 11.5 ± 1.2 | 9.0–14.1 | ||
| PT + LN (n = 37) | Survival | 22 | 23.7 ± 1.7 | 20.3–27.1 | 0.19 |
| Death | 15 | 27.3 ± 2.1 | 23.1–31.5 |
* Mann–Whitney U-test; CNB, core needle biopsy; PT, primary tumor; LN, metastatic lymph node.